SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PCRX - Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process

Story updates

12:00:58 PM UTC
SquawkNews
PCRX Pacira Biosciences advances pcrx-201 development program with successful transition to scalable commercial manufacturing process Pacira Biosciences - part a ascend enrollment concluded; topline data expected by end of 2026

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.